Upgrade to SI Premium - Free Trial

Clene (CLNN)

5.92 +0.07 (1.20%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/17/26)

Latest Headlines

Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis June 22, 2026 8:30 AM - StreetInsider Form 4 Clene Inc. For: Jun 11 Filed by: Mortenson Mark June 15, 2026 2:24 PM - SEC Filing Form 4 Clene Inc. For: Jun 11 Filed by: Etherington Robert Dee June 15, 2026 2:23 PM - SEC Filing Form 4 Clene Inc. For: Jun 11 Filed by: BROWN MORGAN R June 15, 2026 2:23 PM - SEC Filing Form S-8 Clene Inc. June 5, 2026 4:10 PM - SEC Filing Form SD Clene Inc. May 22, 2026 4:44 PM - SEC Filing Form 8-K Clene Inc. For: May 18 May 22, 2026 4:37 PM - SEC Filing Form 4 Clene Inc. For: May 21 Filed by: McLaughlin Vallerie May 22, 2026 2:03 PM - SEC Filing Form 4 Clene Inc. For: May 21 Filed by: Desai Arjun JJ May 22, 2026 2:02 PM - SEC Filing Form 4 Clene Inc. For: May 21 Filed by: Mosca Alison May 22, 2026 2:02 PM - SEC Filing Form 4 Clene Inc. For: May 21 Filed by: MATLIN DAVID J May 22, 2026 1:59 PM - SEC Filing Form 4 Clene Inc. For: May 21 Filed by: Jacobovitz Shalom May 22, 2026 1:58 PM - SEC Filing Form 4 Clene Inc. For: May 21 Filed by: Kiernan Matthew May 22, 2026 1:55 PM - SEC Filing Form 4 Clene Inc. For: May 21 Filed by: Gay Jonathon May 22, 2026 1:55 PM - SEC Filing Form 4 Clene Inc. For: May 21 Filed by: WILCOX REED N May 22, 2026 1:54 PM - SEC Filing Form SCHEDULE 13G/A Clene Inc. Filed by: Ugwumba Chidozie May 15, 2026 2:56 PM - SEC Filing Form SCHEDULE 13G/A Clene Inc. Filed by: Mosca Alison May 14, 2026 9:03 PM - SEC Filing Form SCHEDULE 13G/A Clene Inc. Filed by: Ugwumba Chidozie May 14, 2026 5:18 PM - SEC Filing Form 8-K Clene Inc. For: May 11 May 14, 2026 8:02 AM - SEC Filing Clene Reports First Quarter 2026 Financial Results and Recent Operating Highlights May 14, 2026 8:00 AM - Globe NewsWire Form 10-Q Clene Inc. For: Mar 31 May 14, 2026 7:55 AM - SEC Filing Form 4 Clene Inc. For: May 11 Filed by: Ugwumba Chidozie May 13, 2026 6:04 PM - SEC Filing Form SCHEDULE 13G/A Clene Inc. Filed by: Vivo Opportunity Fund Holdings, L.P. May 12, 2026 9:46 PM - SEC Filing Form 144 Clene Inc. Filed by: SymBiosis Capital Partners, LLC May 11, 2026 4:16 PM - SEC Filing Clene, Inc. (CLNN) PT Raised to $50 at Canaccord May 8, 2026 6:48 AM - StreetInsider Form 4 Clene Inc. For: May 01 Filed by: Ugwumba Chidozie May 5, 2026 5:54 PM - SEC Filing Form 8-K Clene Inc. For: May 05 May 5, 2026 5:06 PM - SEC Filing Clene (CLNN) launches share offering May 5, 2026 5:04 PM - StreetInsider Form 424B5 Clene Inc. May 5, 2026 5:04 PM - SEC Filing Form 424B5 Clene Inc. May 5, 2026 5:02 PM - SEC Filing Clene raises $7 million through stock offering at $7 per share May 5, 2026 8:45 AM - StreetInsider Clene Announces $7 Million Underwritten Offering of Common Stock May 5, 2026 8:45 AM - Globe NewsWire Clene to Present at Upcoming May Conferences May 5, 2026 8:01 AM - Globe NewsWire Presenting on Emerging Growth Conference 92 Day 1 on May 6; Register to live stream May 5, 2026 7:00 AM - Globe NewsWire Form 144 Clene Inc. Filed by: SymBiosis Capital Partners, LLC May 4, 2026 4:03 PM - SEC Filing Form 8-K Clene Inc. For: May 04 May 4, 2026 8:03 AM - SEC Filing Clene plans accelerated FDA filing for ALS drug CNM-Au8 in Q3 2026 May 4, 2026 8:01 AM - StreetInsider After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS May 4, 2026 8:00 AM - Globe NewsWire Form 4 Clene Inc. For: Apr 28 Filed by: Ugwumba Chidozie April 30, 2026 5:55 PM - SEC Filing Form 144 Clene Inc. Filed by: SymBiosis Capital Partners, LLC April 28, 2026 4:10 PM - SEC Filing Full Article List